|
|
Volumn 17, Issue 1, 1996, Pages 1-3
|
|
Calcium channel blockers or beta receptor antagonists for patients with ischaemic heart disease. What is the best choice?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
METOPROLOL;
METOPROLOL TARTRATE;
NIFEDIPINE;
VERAPAMIL;
ACUTE HEART INFARCTION;
ANGINA PECTORIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
EDITORIAL;
HEART INFARCTION;
HUMAN;
ISCHEMIC HEART DISEASE;
MAJOR CLINICAL STUDY;
META ANALYSIS;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
|
|
EID: 0029971555
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1093/oxfordjournals.eurheartj.a014667 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
